These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23383326)

  • 1. Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis.
    Nair Kesavachandran C; Haamann F; Nienhaus A
    PLoS One; 2013; 8(2):e55364. PubMed ID: 23383326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
    Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
    Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.
    Hsieh MC; Yu ML; Chuang WL; Shin SJ; Dai CY; Chen SC; Lin ZY; Hsieh MY; Liu JF; Wang LY; Chang WY
    Eur J Endocrinol; 2000 May; 142(5):431-7. PubMed ID: 10802518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C.
    Vasiliadis T; Anagnostis P; Nalmpantidis G; Soufleris K; Patsiaoura K; Grammatikos N; Orfanou-Koumerkeridou E; Kargiotis K; Slavakis A; Deliyiannidis A; Eugenidis N
    Ann Acad Med Singap; 2011 Sep; 40(9):394-400. PubMed ID: 22065032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
    Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
    Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy.
    Dalgard O; Bjøro K; Hellum K; Myrvang B; Bjøro T; Haug E; Bell H
    J Intern Med; 2002 May; 251(5):400-6. PubMed ID: 11982739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study.
    Bini EJ; Mehandru S
    Arch Intern Med; 2004 Nov; 164(21):2371-6. PubMed ID: 15557418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.
    Loftis JM; Wall JM; Linardatos E; Benvenga S; Hauser P
    J Endocrinol Invest; 2004; 27(7):RC16-20. PubMed ID: 15505982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy.
    Costelloe SJ; Wassef N; Schulz J; Vaghijiani T; Morris C; Whiting S; Thomas M; Dusheiko G; Jacobs M; Vanderpump MP
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):249-56. PubMed ID: 20148905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
    Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
    Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan.
    Chang YK; Tseng YT; Chen KH; Chen KT
    BMC Endocr Disord; 2019 Apr; 19(1):36. PubMed ID: 30953492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C.
    Sachithanandan S; Clarke G; Crowe J; Fielding JF
    J Interferon Cytokine Res; 1997 Jul; 17(7):409-11. PubMed ID: 9243373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
    Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
    Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C.
    Hwang Y; Kim W; Kwon SY; Yu HM; Kim JH; Choe WH
    Korean J Intern Med; 2015 Nov; 30(6):792-800. PubMed ID: 26552454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
    Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
    Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid dysfunction in antiviral therapy of chronic hepatitis C.
    Dabrowska MM; Panasiuk A; Flisiak R
    Hepatogastroenterology; 2010; 57(101):826-31. PubMed ID: 21033237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C virus infection and thyroid diseases].
    Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
    Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.